SCYNEXIS, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
SCYNEXIS, Inc. (SCYX) had Operating Leases, Future Minimum Payments, Due in Four Years of $529.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-11.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-03-11
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $529.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Four Years $518.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Four Years $518.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $518.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $529.00K 10-K · filed 2020-03-11 |
| 2018-09-30 | $518.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $518.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $518.00K 10-Q · filed 2018-05-08 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-07 |
| 2015-09-30 | $182.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $1.16M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $1.16M 8-K · filed 2015-10-30 |
| 2014-12-31 | $1.16M 8-K · filed 2015-10-30 |
| 2014-09-30 | $1.12M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.12M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $1.12M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |